CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

A novel in silico synthesized analog of AM-251 as a candidate antagonist of mu-oipioid receptor

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 52
Year: 2018
COI code: CIGS15_068
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors A novel in silico synthesized analog of AM-251 as a candidate antagonist of mu-oipioid receptor

  Alireza Sharafshah - Cellular and Molecular Research Center, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
  Parvaneh Keshavarz - Cellular and Molecular Research Center, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Abstract:

Introduction: Previous studies demonstrated that the AM-251 directly bind to Mu-Opioid Receptors (MORs). Here, we developed an analog of AM-251 through in silico procedures to find a more effective compound with better affinity for future studies of MOR inhibitors in analgesia.Methods: The tertiary structures of human MOR protein was modeled by Swiss Model, PS2, and Phyre2 online softwares (template PDB ID: 4DJH). Then, best models (from Phyre2) were built after energy minimization by Swiss-PdbViewer DeepView ver. 4.1.0 software. The structures of designed models were then validated using RAMPAGE (95.7% in favored and allowed regions) and ProSA softwares (z-score=-2.33). 45 new analogs of AM-251 were created by adding OH and CH3 substituents to various atoms of AM-251. To prepare the ligand for docking, energy minimization of ligands was performed using Hyperchem ver. 8.0.8. Active site of OPRM1 was predicted by COACH. First, all 45 molecules were docked through Autodock vina in PyRx tool, and then best molecule with lowest energy binding docked again by Autodock vina ver. 4.2. Results: We found that C27 had potential role to be changed by substituents like CH3 and OH. The best conformation was CH3 substituent added to the C27 of AM-251 with binding energy of -9.05 kcal/mol and 2 hydrogen bonds with ASN371 compared to AM-251 Energy binding of -7.9 kcal/mol and no H-bond formation.Conclusion: Suggested in silico synthesized (1‐(2,4‐dichloro‐3‐methylphenyl)‐5‐(4‐iodophenyl)‐4‐methyl‐N‐(piperidin‐1‐yl)‐1H‐pyrazole‐3‐carboxamide) can be an analog candidate of AM-251 as a specific inhibitor of MOR but this needs both chemical and clinical validations.

Keywords:

MOR, AM-251, Homology Modeling, Docking.

Perma Link

https://www.civilica.com/Paper-CIGS15-CIGS15_068.html
COI code: CIGS15_068

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Sharafshah, Alireza & Parvaneh Keshavarz, 2018, A novel in silico synthesized analog of AM-251 as a candidate antagonist of mu-oipioid receptor, The Third International and 15th National Genetics Congress, تهران, انجمن علمي ژنتيك ايران, https://www.civilica.com/Paper-CIGS15-CIGS15_068.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Sharafshah, Alireza & Parvaneh Keshavarz, 2018)
Second and more: (Sharafshah & Keshavarz, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 776
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.